Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
postmarketing
Pharma
Biogen expands Aduhelm confirmatory trial
The planned increase comes as CMS has proposed to limit Aduhelm's Medicare coverage to patients who enroll in a randomized controlled trial.
Angus Liu
Jan 27, 2022 7:30am
Merck pulls Keytruda in SCLC amid 'industrywide' approval review
Mar 2, 2021 9:56am
Philippines officials nix Sanofi's appeal on Dengvaxia ban
Aug 22, 2019 10:53am
True innovation? Agency questions benefits of new drugs
Jul 12, 2019 12:04pm
EMA picks up Xeljanz safety signal, puts Pfizer med under review
Mar 1, 2019 11:25am
Philippine officials pull Sanofi's Dengvaxia license: report
Feb 19, 2019 3:05pm
